Investing Profile

David Rubin

VCInvestor

Managing Director at Merck Global Health Innovation Fund

Your Intro Paths to David Rubin

Signal uses Gmail to reveal intro paths. Email content is never read.

Find David Rubin on

Current Investing Position

Investment Range

$100K - $5.0M

Sweet Spot

$1.5M

Investments On Record

David Rubin is on these Sector & Stage Rankings

David Rubin's Investments On Record (12)

Company	StageDateRound Size	Total Raised
N-Power Medicine	Series BMay 2024
Baseimmune	Series AFeb 2024$11M	$17M
Co-investors: Jamie Macfarlane (Creator Fund), Hussein Kanji (Hoxton Ventures)
Culmination Bio	Series ANov 2023$10M	$10M
Co-investors: Jack Boren
Octave	Series BJul 2023$33M Series UnknownOct 2021	$150M
Co-investors: Mike Pellini (Section 32), Michael Rubin (Northpond Ventures), Julian Harris (Deerfield Management), Saurabh Bhansali (Health Velocity Capital)
Turbine	Series ANov 2022$21M	$130M
Co-investors: Hany Nada (ACME Capital), Alexandre Perrin (Scalebridge Capital), Christian Dahlen (Band of Angels), Vishal Gulati (Molten Ventures), Daniel Waterhouse (Balderton Capital), Anvesh Ramineni (MassMutual Ventures), Richard De Silva, Esther Dyson
PreciseDx	Series AJan 2022$11M	$14M
Co-investors: Martin Alexander Gershon (Endeavor Venture Funds)
Verge Genomics	Series BDec 2021$98M	$130M
Co-investors: Lan Xuezhao (Basis Set Ventures), Henry McNamara (Great Oaks Venture Capital), Andrew Boszhardt (Great Oaks Venture Capital), Jesse Beyroutey (IA Ventures), Kimberly Vogel
Ciox Health	Private EquityJul 2019$30M	$30M

Investors who invest with David Rubin

Founders who looked at David Rubin's profile also looked at these Scouts & Angels